HDAC6 and cancer: Further analysis of the clinicopathological characteristics in paired HCC and adjacent nontumor tissues indicated that upregulation of microtubule acetylation or downregulation of HDAC6 was significantly correlated with malignant tumor progression (Tables S6 and S7) and poor prognosis (Figure 7C).